Skip to main content
. 2022 Dec 28;159(2):160–171. doi: 10.1001/jamadermatol.2022.5508

Table 2. Results of Random Effects Analysis: Risk Ratio for Each Clinical Risk Factor for Local Recurrence, Nodal Metastasis, and Disease-Specific Death.

Risk factor Risk ratio (95% CI) P value Studies, No. I2statistic, %
Local recurrence
HIV 7.0 (2.1-23.1) .001 2 0
Organ transplantation 4.0 (2.2-7.0) <.001 4 5
Chronic lymphocytic leukemia 3.8 (1.5-9.8) .005 1 0
Age >65 y 2.3 (0.5-9.9) .26 1 0
Tumor on ear or lip 2.0 (0.6-6.8) .26 1 0
Tumor on head or neck 1.9 (0.9-3.9) .09 5 0
Ulceration 1.7 (1.2-2.4) .001 4 0
Tumor on scalp 1.7 (0.8-3.6) .21 3 0
Age >70 y 1.6 (0.5-5.0) .46 2 0
Tumor on ear 1.5 (0.8-3.1) .23 6 0
Immunosuppression 1.5 (1.1-2.2) .03 14 0
Growth rate ≥4 mm/mo 1.4 (0.5-4.1) .50 1 0
Tumor on lip 1.4 (0.6-3.6) .45 4 0
Male sex 1.2 (0.9-1.6) .13 10 0
Age >60 y 1.0 (0.4-2.9) .96 1 0
Age >75 y 0.9 (0.5-1.5) .91 3 9
Nodal metastasis
Organ transplant 38.6 (21.2-70.3) <.001 2 0
Chronic lymphocytic leukemia 4.5 (2.1-9.5) <.001 1 0
Hypothyroidism 4.0 (2.8-5.7) <.001 1 0
Age >65 y 3.9 (1.7-8.9) .001 1 0
Growth rate ≥4 mm/mo 3.2 (1.1-9.7) .04 1 0
Tumor on ear or lip 2.9 (1.4-5.9) .003 1 0
HIV 2.8 (0.8-10.3) .11 1 0
Age >70 y 2.7 (1.4-5.0) .003 1 0
Immunosuppression 2.6 (2.2-3.0) <.001 8 17
Tumor on scalp 2.5 (1.3-4.6) .004 4 0
Tumor on lip 2.3 (1.4-3.9) .002 6 5
Hematologic malignant tumor 2.1 (0.4-11.3) .38 1 0
Diabetes 1.8 (0.3-12.1) .53 1 0
Tumor on ear 1.8 (1.4-2.2) <.001 9 12
Male sex 1.5 (1.1-1.9) .002 8 3
Tumor on head or neck 1.3 (0.9-2.0) .14 4 0
Age >75 y 1.3 (0.3-5.9) .76 2 0
Smoking history 1.1 (0.7-1.7) .75 1 0
Disease-specific death
Tumor on head or neck 4.4 (1.6-12.2) .005 1 0
Organ transplant 4.1 (0.7-24.2) .12 1 0
Immunosuppression 2.7 (1.6-4.5) <.001 9 36
Ulceration 2.2 (1.2-4.1) .01 1 0
Male sex 1.8 (0.4-8.6) .45 3 0
Tumor on ear 1.4 (0.5-3.9) .58 2 8
Tumor on lip 1.0 (0.7-1.3) .94 2 0
Tumor on ear or lip 0.9 (0.2-3.8) .90 1 0
Age >65 y 0.5 (0.2-1.1) .10 1 0